Download PDF
Pharmacopsychiatry 2021; 54(04): 149-150
DOI: 10.1055/a-1520-5020
Editorial

Psychedelics: A New Treatment Paradigm in Psychiatry?

Gerhard Gründer
1   Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

The renaissance of psychedelics has accelerated further over the past year. At least that’s true if you follow the public press. The New York Times recently titled “The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.” on its front page [1].



Publication History

Received: 25 May 2021
Received: 25 May 2021

Accepted: 26 May 2021

Article published online:
24 June 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 The New York Times. The psychedelic revolution is coming. Psychiatry may never be the same. 2021; https://www.nytimes.com/2021/05/09/health/psychedelics-mdma-psilocybin-molly-mental-health.html (accessed on May 21st, 2021)
    PubMed
  • 2 Mitchell JM, Bogenschutz M, Lilienstein A. et al. MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021
    CrossrefPubMedSearch in Google Scholar
  • 3 Carhart-Harris R, Giribaldi B, Watts R. et al. trial of psilocybin versus escitalopram for depression. N Engl J Med 2021; 384: 1402-1411
    CrossrefPubMedSearch in Google Scholar
  • 4 Yaden DB, Yaden ME, Griffiths RR. psychedelics in psychiatry-keeping the renaissance from going off the rails. J Am Med Assoc Psychiatry 2021; 78: 469-470
    PubMedSearch in Google Scholar
  • 5 Nichols DE, Walter H. The history of psychedelics in psychiatry. Pharmacopsychiatry. 2021; 54: 151-166
    Thieme ConnectPubMedSearch in Google Scholar
  • 6 Nayak S, Johnson MW. Psychedelics and psychotherapy. Pharmacopsychiatry. 2021; 54: 167-175
    Thieme ConnectPubMedSearch in Google Scholar
  • 7 Mertens LJ, Preller KH. Classical psychedelics as therapeutics in psychiatry—current clinical evidence and potential therapeutic mechanisms in substance use and mood disorders. Pharmacopsychiatry. 2021; 54: 176-190
    Thieme ConnectPubMedSearch in Google Scholar
  • 8 Gründer G, Jungaberle H. The potential role of psychedelic drugs in mental health care of the future. Pharmacopsychiatry. 2021; 54: 191-199
    Thieme ConnectPubMedSearch in Google Scholar